Coherus Oncology, Inc. Earnings Per Share (Diluted)
Coherus Oncology, Inc. (CHRS) reported Earnings Per Share (Diluted) of -$0.13 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-05
- Coherus Oncology, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.13, a 105.06% decline year-over-year.
- Coherus Oncology, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.28, a 110.89% decline year-over-year.
- Coherus Oncology, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.31.
- Coherus Oncology, Inc. earnings per share, diluted for the quarter ending 2025-06-30 was $2.57.
- Coherus Oncology, Inc. earnings per share, diluted for fiscal 2025 was $1.43, a 472.00% increase from fiscal 2024.
- Coherus Oncology, Inc. earnings per share, diluted for fiscal 2024 was $0.25.
- Coherus Oncology, Inc. earnings per share, diluted for fiscal 2022 was -$3.76.
- Coherus Oncology, Inc. earnings per share, diluted for fiscal 2021 was -$3.81, a 335.19% decline from fiscal 2020.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.13 10-Q · filed 2026-08-05 | -$0.40 10-Q · filed 2026-08-05 | |||||
| 2026-03-31 | -$0.28 10-Q · filed 2026-05-11 | ||||||
| 2025-12-31 | $1.43 10-K · filed 2026-03-09 | ||||||
| 2025-09-30 | -$0.31 10-Q · filed 2025-11-06 | $1.77 10-Q · filed 2025-11-06 | |||||
| 2025-06-30 | $2.57 10-Q · filed 2026-08-05 | $2.08 10-Q · filed 2026-08-05 | |||||
| 2025-03-31 | $2.57 10-Q · filed 2026-08-05 | -$0.49 10-Q · filed 2025-05-12 | |||||
| 2024-12-31 | $0.25 10-K · filed 2026-03-09 | ||||||
| 2024-09-30 | -$0.09 10-Q · filed 2025-11-06 | $0.69 10-Q · filed 2025-11-06 | $0.65 10-Q · filed 2024-11-06 | ||||
| 2024-06-30 | -$0.11 10-Q · filed 2025-08-07 | $0.79 10-Q · filed 2025-08-07 | $0.73 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | $0.91 10-Q · filed 2025-05-12 | $0.83 10-Q · filed 2024-05-09 | |||||
| 2023-12-31 | -$2.53 8-K · filed 2025-11-13 | ||||||
| 2023-09-30 | -$0.41 10-Q · filed 2024-11-06 | -$1.79 10-Q · filed 2024-11-06 | |||||
| 2023-06-30 | -$0.49 10-Q · filed 2024-08-08 | -$1.42 10-Q · filed 2024-08-08 | |||||
| 2023-03-31 | -$0.96 10-Q · filed 2024-05-09 | ||||||
| 2022-12-31 | -$3.76 10-K · filed 2025-03-17 | ||||||
| 2022-09-30 | -$1.11 10-Q · filed 2023-11-06 | -$3.00 10-Q · filed 2023-11-06 | |||||
| 2022-06-30 | -$0.65 10-Q · filed 2023-08-02 | -$1.89 10-Q · filed 2023-08-02 | |||||
| 2022-03-31 | -$1.24 10-Q · filed 2023-05-08 | ||||||
| 2021-12-31 | -$3.81 10-K · filed 2024-03-15 | ||||||
| 2021-09-30 | -$0.49 10-Q · filed 2022-11-08 | -$3.22 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | -$0.40 10-Q · filed 2022-08-04 | -$2.73 10-Q · filed 2022-08-04 | |||||
| 2021-03-31 | -$2.37 10-Q · filed 2022-05-05 | ||||||
| 2020-12-31 | $1.62 10-K · filed 2023-03-06 | ||||||
| 2020-09-30 | $0.33 10-Q · filed 2021-11-08 | $1.52 10-Q · filed 2021-11-08 | |||||
| 2020-06-30 | $0.70 10-Q · filed 2021-08-05 | $1.20 10-Q · filed 2021-08-05 | |||||
| 2020-03-31 | $0.48 10-Q · filed 2021-05-06 | ||||||
| 2019-12-31 | $0.53 10-K · filed 2020-02-27 | $1.23 10-K · filed 2022-02-23 | |||||
| 2019-09-30 | $0.63 10-Q · filed 2020-11-05 | $0.69 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $0.32 10-Q · filed 2020-08-06 | $0.05 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | -$0.29 10-Q · filed 2020-05-07 | ||||||
| 2018-12-31 | -$3.22 10-K · filed 2021-02-25 | ||||||
| 2018-09-30 | -$0.87 10-Q · filed 2019-11-08 | -$2.39 10-Q · filed 2019-11-08 | |||||
| 2018-06-30 | -$0.68 10-Q · filed 2019-08-05 | -$1.42 10-Q · filed 2019-08-05 | |||||
| 2017-12-31 | -$4.48 10-K · filed 2020-02-27 | ||||||
| 2017-09-30 | -$1.09 10-Q · filed 2017-11-06 | -$3.68 10-Q · filed 2017-11-06 | |||||
| 2016-12-31 | -$1.71 10-K · filed 2018-03-08 | ||||||
| 2016-09-30 | $1.67 10-K · filed 2018-03-08 | -$1.25 10-Q · filed 2017-11-06 | |||||
| 2016-06-30 | -$1.72 10-K · filed 2018-03-08 | ||||||
| 2016-03-31 | -$1.67 10-K · filed 2018-03-08 | ||||||
| 2015-09-30 | -$1.86 10-Q · filed 2016-11-09 | -$4.68 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |